Oramed Pharmaceuticals Inc. (ORMP)

Market
Nasdaq
Sector
Healthcare
Trend
Strong uptrend
Last close
5.01 (+1.62% on the day)
MA50
4.46
MA200
3.7
52-week range
2.04–5.34
Market cap
208.8M USD
P/E
1.22
Dividend yield
0%
Data as of
2026-09-04
Quarterly revenue and earnings, millions of USD
QuarterRevenueYoY %EarningsYoY %
Q1 20252-7.6
Q2 2025013.3
Q3 2025048.4
Q4 2025010
Q1 20260-100%38.3

All markets — KeepWinning global stock screener

Other companies on Nasdaq: Coherus Oncology, Inc. (CHRS), First Capital, Inc. (FCAP), PepGen Inc. (PEPG), Eagle Nuclear Energy Corp. (NUCL), Acumen Pharmaceuticals, Inc. (ABOS), TOYO Co., Ltd. (TOYO)